30 results
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
based on the securities offered and the number of issuances and accordingly cannot be estimated at this time.
Excludes registration fee offset
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
was carried forward and used to offset the registration fees due for the 2021 Securities (as defined below).
On August 5, 2021, the registrant filed … of the 2021 Registration Statement on August 5, 2021, and (ii) an offset of $9,218 of the registration fee required to be paid thereunder based
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
, partially offset by increases of $0.3 million of R&D expenses for both setrusumab and alvelestat.
The reduction in etigilimab expenses was primarily due … to reimburse certain expenses incurred by us in respect of our ADR program, partially offset by an increase in employee-related expenses and professional fees
8-K
EX-99.1
MREO
Mereo Biopharma Group Plc
15 May 24
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
in the first quarter of 2024. The decrease was primarily due to a $1.8 million reduction in R&D expenses for etigilimab, partially offset by increases … of 2024 for amounts from our depository to reimburse certain expenses incurred by us in respect of our ADR program, partially offset by an increase
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, we are entitled to offset a specified percentage of amounts paid to such third parties in consideration for such intellectual property rights against … . The availability to carry forward and offset these tax loss carry-forwards against future operating profits is subject to certain restrictions.
As a company
10-K
EX-10.30
i3u6z76nh2gy5 sx77
27 Mar 24
Annual report
5:20pm
8-K
EX-99.1
l2lc8mfmlzyk oo9p
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
6-K
EX-99.2
77c ddt2qx8
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
hrelptt z7lmppid4
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
yqv9cloc
2 Nov 21
Current report (foreign)
4:16pm
F-3/A
gn4311tx
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
izb5o9r 11d1
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
1z4qllva
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-99.1
80mazo694kv
16 Apr 21
Current report (foreign)
4:10pm
6-K
EX-99.1
cupzy go6
31 Mar 21
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights
5:13pm
F-3
fvxtgo tmhpsilz
6 Jul 20
Shelf registration (foreign)
4:58pm
6-K
uleut ssa3gk0
16 Jun 20
Current report (foreign)
4:13pm